Efficacy and Safety Aspects of Renal Denervation in Treatment of Arterial Hypertension: A Systematic Review and Meta-analysis
D Vukadinovic
Compared to sham, renal denervation (RDN) was associated with
Reduced ambulatory and office SBP
No safety concerns
New approaches for the prediction and prevention of ventricular arrhythmias and sudden cardiac death in ischaemic heart disease
Temporal Trends in Baseline Characteristics of Implantable Cardioverter Defibrillator Recipients for Primary Prevention of Sudden Cardiac Death- The DAIPP Program
D Frodi
The primary prevention Implantable Cardioverter Defibrillators (ICD) changed over time
Perioperative complications decreased over time
Increase in use of 2 or 3 medications
Coronary heart disease risk prediction in asymptomatic patients: what works best?
Lost in Math: Risk Calculators
Ian M Graham
The new SCORE2-OP model
Estimates the risk of fatal and non-fatal CVD for older persons
SCORE2-OP is recalibrated for use in 4 European risk regions
Individual predictions of CVD risk and treatment benefits can be used in shared decision-making
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa McDonagh
The guidelines recommended
Intravenous (IV) iron supplementation in symptomatic patients with HFrEF and HFmrEF
IV supplementation to alleviate HF symptoms
Improve quality of life
Reduce risk of HF hospitalization
HOTLINE
ATTRibute-CM trial
Acoramidis met 30-month primary endpoint
Consistent treatment shows
Better preservation of exercise capacity and QoL
Reduced NT-proBNP levels in 45% of patients
81% survival rate
Reassuring safety profile
HOTLINE
ARREST Trial: Expedited Transfer to a Cardiac Arrest Centre for Non-ST Elevation OHCA
T Patterson
Transfer to the cardiac arrest centre in adult patients without ST elevation demonstrated
No reduction in mortality at 30 days
No difference in neurological outcomes
Efficacy and Safety of Intravenous Iron Repletion in Patients with Heart Failure: A Systemic Review
FCM/FDI reduced HFH and CVD
No heterogeneity between FCM and FDI
FCM/FDI have favourable safety profile
Coronary heart disease risk prediction in asymptomatic patients: what works best?
Show Me the Moves: Stress Testing
M Guazzi
Small changes in CRF and CV mortality over time have huge impact
CPET–derived data out of peak VO2 are
Highly prognostic in HF populations
Can predict worse CV outcome in general population
